Trials / Completed
CompletedNCT05290246
TRE in Type 2 Diabetes (See Food Study 3)
TRE in Type 2 Diabetes Mellitus (See Food Study 3)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients \[BMI:25-45 kg/m2\] with metformin-only treated Type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Time restricted eating | Limiting daily eating time to an 8 hour window |
| BEHAVIORAL | Caloric reduction | Cut caloric intake by 15% |
Timeline
- Start date
- 2022-05-27
- Primary completion
- 2025-12-12
- Completion
- 2026-03-23
- First posted
- 2022-03-22
- Last updated
- 2026-04-14
- Results posted
- 2026-03-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05290246. Inclusion in this directory is not an endorsement.